Literature DB >> 25760172

[Evaluation of knowledge on blood pressure levels and chronicity of hypertension among users of a public pharmacy in Southern Brazil].

Fabiane Raquel Motter, Maria Teresa Anselmo Olinto, Vera Maria Vieira Paniz.   

Abstract

The aim of this study was to evaluate patients' knowledge on hypertension and associated factors through a cross-sectional study of adults using antihypertensive medication dispensed by the São Francisco de Paula Public Pharmacy in Rio Grande do Sul State, Brazil. The study evaluated knowledge on the normal limits for systolic and diastolic blood pressure and chronicity of hypertension. Multinomial regression was used to measure knowledge (satisfactory/moderate/unsatisfactory); satisfactory was defined as correct knowledge on two or more items. Of the 635 users with hypertension, 27.7% showed satisfactory knowledge, while 47.2% were only aware of the chronic nature of hypertension. After adjustment, female gender, more education, not living alone, healthy lifestyle, and greater time since diagnosis were associated with satisfactory knowledge on hypertension. Considering the importance of patient autonomy in monitoring blood pressure and continuous treatment to control hypertension, the study showed a low prevalence of satisfactory knowledge.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25760172     DOI: 10.1590/0102-311x00061914

Source DB:  PubMed          Journal:  Cad Saude Publica        ISSN: 0102-311X            Impact factor:   1.632


  2 in total

1.  Factors associated with not adopting healthy behavior among hypertensive individuals: a population-based study in Brazil.

Authors:  Franciele A V Dionato; Carla C Enes; Luciana B Nucci
Journal:  J Hum Hypertens       Date:  2020-07-27       Impact factor: 3.012

2.  Hypertensives' Knowledge About High-Sodium Foods and Their Behavior.

Authors:  Juliana de Fátima Teixeira; Maíra Ribas Goulart; Fernanda Michielin Busnello; Lucia Campos Pellanda
Journal:  Arq Bras Cardiol       Date:  2016-04-15       Impact factor: 2.000

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.